Zoo Pharma Dynamics, Inc
PRODUCTS
Research
Zoo Pharma Dynamics (ZPD) is committed to driving innovation in animal healthcare and nutrition through rigorous research and development. Specializing in pharmacognosy, the company focuses on utilizing natural, Non-GMO, and organic extracts to develop effective solutions for hoofed livestock, pets, and exotic wildlife.
Areas of Research
Investigating the ecology, transmission mechanisms, and spillover pathways of endemic and emerging zoonotic pathogens within livestock and wildlife reservoirs.
Researching how optimized animal nutrition affects immune function and disease resistance, reducing the need for antimicrobial interventions.
Researching alternatives to antibiotic use in animal agriculture to prevent antimicrobial resistance (AMR), including the development of natural, anti-inflammatory, and antimicrobial compounds.
"We continue to push the boundaries of veterinary science, investing deeply in research and development to pioneer the next generation of life-saving treatments and diagnostics for animals everywhere."
ZPD collaborates with and contracts with industry partners
with our research and development.
Featured Research
Zoo Pharma Dynamics possesses four formulations that are presently awaiting patent approval and are trademarked as CPP. Currently, ZPD is actively engaged in the new drug approval process with the FDA/CVM, employing open INADE and ONADE files. Our researchers have discovered that lichen extracts facilitate the degradation of PrPTSE within brain homogenate, as well as cause degradation of PrP in a CWD-infected white-tailed deer.
Through our rigorous field trial protocols, we consistently conduct research and development to further enhance our effective treatments for cervids infected with the Prion disease CWD. This allows us to stay at the forefront of innovative solutions in our ongoing efforts to combat this disease.
